Regulations.gov document
Exhibit L - "FDA Letter to Andrx Pharmacuetical, Inc., re Omeprazole, November 16, 2001"…
Supporting & Related Material · FDA-2010-P-0188 · posted Apr 8, 2010
Key facts
| Document ID | FDA-2010-P-0188-0008 |
|---|---|
| Title | Exhibit L - "FDA Letter to Andrx Pharmacuetical, Inc., re Omeprazole, November 16, 2001" - [Actavis Elizabeth LLC (Axinn, Veltrop & Harkrider LLP) - Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2010-P-0188 |
| Posted | Apr 8, 2010 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: